Evidence map›Paper›PMID 36891473›Full record

ArticleFrontiers in neurology2023

A homozygous

Hong-Xing Li, Mei Dong, Xiao-Xiao Peng, Yi-Zhe Liu, Han Wang, Chao Li, Yi-Yi Du, Kai Zhang, Qiang Zong

Open access · goldAbstract read
In one paragraph

Article in Frontiers in neurology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 48% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Hong-Xing LiDepartment of Neurosurgery, Shengli Oilfield Central Hospital, Dongying, Shandong, China.
Mei DongDepartment of Neurosurgery, Shengli Oilfield Central Hospital, Dongying, Shandong, China.
Xiao-Xiao PengDepartment of Stomatology, Dongying District People's Hospital, Dongying, Shandong, China.
Yi-Zhe LiuDepartment of Neurosurgery, Shengli Oilfield Central Hospital, Dongying, Shandong, China.
Han WangDepartment of Neurosurgery, Shengli Oilfield Central Hospital, Dongying, Shandong, China.
Chao LiDepartment of Neurosurgery, Shengli Oilfield Central Hospital, Dongying, Shandong, China.
Yi-Yi DuDepartment of Neurosurgery, Shengli Oilfield Central Hospital, Dongying, Shandong, China.
Kai ZhangDepartment of Neurosurgery, Shengli Oilfield Central Hospital, Dongying, Shandong, China.
Qiang ZongDepartment of Neurosurgery, Shengli Oilfield Central Hospital, Dongying, Shandong, China.
Shengli Oilfield Central Hospital · CNDongyang People's Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Although Parkinson's disease (PD) is the second most common neurodegenerative disorder, pregnancy in patients with PD is a relatively rare occurrence because the most common age of onset of PD is beyond the childbearing age, except in patients with Young-Onset PD (YOPD) caused by parkin RBR E3 ubiquitin protein ligase ( Case: In this study, we report the case of a 30-year-old Chinese woman who was affected by Conclusion: This case further suggests that levodopa/benserazide during pregnancy is safe in the treatment of

Indexed as

levodopa/benserazideParkinson's diseasepregnancyPRKN geneyoung-onset PD

Identifiers

PMID36891473
PMCPMC9986302
OpenAlexW4321377276

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.